Targeting benign prostate hyperplasia treatments: AR/TGF-ß/NOX4 inhibition by apocynin suppresses inflammation and proliferation.

Jin, Bo-Ram; Kim, Hyo-Jung; Na, Jung-Hyun; Lee, Won-Kyu; An, Hyo-Jin

Jin, Bo-Ram; Kim, Hyo-Jung; Na, Jung-Hyun; Lee, Won-Kyu; An, Hyo-Jin.

Affiliation

Jin BR; Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea. Electronic address: wlsqh92@khu.ac.kr.
Kim HJ; Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea. Electronic address: hyojung_95@khu.ac.kr.
Na JH; School of Biopharmaceutical and Medical Sciences, Sungshin Women's University, Seoul, Republic of Korea. Electronic address: jhna@sungshin.ac.kr.
Lee WK; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Chungcheongbuk-do, 28160, Republic of Korea. Electronic address: gre7@kbiohealth.kr.
An HJ; Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea; Department of Integrated Drug Development and Natural Products, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea. Electronic address: hjan@khu.ac.kr.

J Adv Res ; 57: 135-147, 2024 Mar.

Article de En | MEDLINE | ID: mdl-37061215

Sujet(s)
Mots clés

Apocynin, Androgen receptor; Benign prostatic hyperplasia; Dihydrotestosterone; NOX4; Prostate cancer prevention

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Acétophénones / Hyperplasie de la prostate / Androgènes Type d'étude: Prognostic_studies Limites: Animals / Humans / Male Langue: En Journal: J Adv Res Année: 2024 Type de document: Article Pays de publication: Égypte

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google